Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Disorder of Endocrine Pancreas”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Looking for participantsNCT05262491
What this trial is testing

BL-B01D1 in Patients With Locally Advanced or Metastatic Gastrointestinal Tumor and Other Solid Tumor

Who this might be right for
Gastrointestinal Tumor
Sichuan Baili Pharmaceutical Co., Ltd. 96
Large-scale testing (Phase 3)UnknownNCT03398291
What this trial is testing

Simultaneous Resection of Pancreatic Cancer and Liver Oligometastasis After Induction Chemotherapy

Who this might be right for
Pancreatic CancerLiver MetastasesSurgery
Fudan University 300
Not applicableUnknownNCT05549960
What this trial is testing

Pre-planning Mathematical Models in EUS-guided Laser Ablation of Pancreatic Lesions

Who this might be right for
Pancreatic Neoplasms
Campus Bio-Medico University 10
Not applicableStudy completedNCT03844789
What this trial is testing

T:Slim X2 With Control-IQ Technology

Who this might be right for
Type 1 Diabetes Mellitus
University of Virginia 101
Very early researchWithdrawnNCT04123574
What this trial is testing

A Pilot Study of BXCL701 in Patients With Pancreatic Cancer

Who this might be right for
Cancer of PancreasCancer of the PancreasNeoplasms, Pancreatic+2 more
BioXcel Therapeutics Inc
Early research (Phase 1)Study completedNCT00266097
What this trial is testing

Oxaliplatin, Gemcitabine, Erlotinib, and Radiation Therapy in Treating Patients With Unresectable and/or Metastatic Pancreatic Cancer or Biliary Tract Cancer

Who this might be right for
Extrahepatic Bile Duct CancerGallbladder CancerPancreatic Cancer
UNC Lineberger Comprehensive Cancer Center 23
Not applicableStudy completedNCT06106568
What this trial is testing

An Observational Study to Learn More About the Impact of Gadoxetate Sodium-Enhanced Magnetic Resonance Imaging (EOB-MRI) When Used to Diagnose the Spread of Cancer From the Pancreas to the Liver in Japanese People Under Real-World Conditions

Who this might be right for
Metastatic Pancreatic CancerLiver MetastasesGadoxetate Sodium-enhanced Magnetic Resonance Imaging
Bayer 39,624
Post-approval studies (Phase 4)Study completedNCT03004612
What this trial is testing

Effect of Linagliptin + Metformin vs Metformin Alone in Patients With Prediabetes

Who this might be right for
Prediabetic StateInsulin Resistance
Universidad de Guanajuato 144
Not applicableStudy completedNCT04596865
What this trial is testing

Recurrence After Whipple's (RAW) Study

Who this might be right for
Pancreatic CancerAmpullary CancerBile Duct Cancer+11 more
University Hospital Plymouth NHS Trust 1,484
Early research (Phase 1)Study completedNCT00030498
What this trial is testing

Erlotinib in Treating Patients With Solid Tumors and Liver or Kidney Dysfunction

Who this might be right for
Adult Anaplastic AstrocytomaAdult Anaplastic EpendymomaAdult Anaplastic Oligodendroglioma+83 more
National Cancer Institute (NCI) 75
Early research (Phase 1)Ended earlyNCT01192763
What this trial is testing

RO4929097 Before Surgery in Treating Patients With Pancreatic Cancer

Who this might be right for
Adenocarcinoma of the PancreasStage IA Pancreatic CancerStage IB Pancreatic Cancer+2 more
National Cancer Institute (NCI) 30
Not applicableLooking for participantsNCT06694792
What this trial is testing

Integration of Multiomics Markers for Invasive IPMNs Identification Through the Set-up of the INvasive Cyst bIomarkers Detection (INCITE) Consortium

Who this might be right for
IPMN, Pancreatic
IRCCS San Raffaele 800
Large-scale testing (Phase 3)UnknownNCT01586611
What this trial is testing

See if hENT1 Testing on Tumour Tissue Can Predict Response to Treatment With Gemcitabine Chemotherapy and if a Different Chemotherapy Called FOLFOX is Better Than Gemcitabine in Metastatic Pancreas Cancer

Who this might be right for
Metastatic Pancreas Cancer
AHS Cancer Control Alberta 175
Not applicableLooking for participantsNCT07124000
What this trial is testing

DESTINY-PANTUMOUR04

Who this might be right for
Adenocarcinoma (NOS)Anal CancerBladder Cancer+24 more
AstraZeneca 100
Not applicableStudy completedNCT01441492
What this trial is testing

Pancreas Resection With and Without Drains

Who this might be right for
Pancreas TumorPancreatitis
Baylor College of Medicine 399
Not applicableLooking for participantsNCT02838836
What this trial is testing

Tumor Cell and DNA Detection in the Blood, Urine and Bone Marrow of Patients With Solid Cancers

Who this might be right for
Non-small Cell Lung CancerEsophageal CancerGastric Cancer+3 more
University of Missouri-Columbia 620
Not applicableStudy completedNCT03003936
What this trial is testing

Glucose Tolerance, Meal Timing and MTNR1B

Who this might be right for
Non-Diabetic Disorder of Endocrine Pancreas
Universidad de Murcia 280
Not applicableStudy completedNCT00246844
What this trial is testing

Assessment of Insulin Production From Native Pancreas in Patients With Pancreas Transplants

Who this might be right for
Long-Functioning Pancreas AllograftsPancreas Transplant
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 10
Not applicableApproved For MarketingNCT03906331
What this trial is testing

Expanded Access for the Treatment of Cancers With Rearranged During Transfection (RET) Activation

Who this might be right for
Non Small Cell Lung CancerMedullary Thyroid CancerColon Cancer+4 more
Eli Lilly and Company
Testing effectiveness (Phase 2)Looking for participantsNCT07148128
What this trial is testing

Phase 1/2a Study to Assess the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of WEF-001 as Monotherapy in Advanced KRAS-Mutant Solid Tumours.

Who this might be right for
Advanced or Metastatic KRAS-mutant Tumor in Pancreatic AdenocarcinomaAdvanced or Metastatic KRAS-mutant Tumor in Colorectal CancerAdvanced or Metastatic KRAS-mutant Tumor in Non Small Cell Lung Cancer+2 more
Auricula Biosciences Inc.
Next Page
110